Genedrive Plc (GDR.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 158 | 60 | 119 | 1,256 | -606 |
| Other Working Capital | 847 | -210 | -302 | 1,308 | 44 |
| Other Operating Activity | -4,791 | -3,471 | -2,364 | -4,401 | -2,939 |
| Operating Cash Flow | $-3,786 | $-3,621 | $-2,547 | $-1,837 | $-3,501 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -97 | -24 | -70 | -164 |
| Other Investing Activity | -2 | -225 | 970 | 14 | 7 |
| Investing Cash Flow | $-42 | $-322 | $946 | $-56 | $-157 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 2,366 | N/A | N/A | N/A |
| Debt Repayment | -685 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,546 | 3,243 | 0 | 6,023 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | 0 | -44 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -304 |
| Financing Cash Flow | $6,861 | $5,609 | $0 | $6,023 | $-348 |
| Exchange Rate Effect | 1 | -11 | 1 | -115 | 192 |
| Beginning Cash Position | 5,184 | 3,529 | 5,129 | 1,114 | 4,928 |
| End Cash Position | 8,218 | 5,184 | 3,529 | 5,129 | 1,114 |
| Net Cash Flow | $3,033 | $1,666 | $-1,601 | $4,130 | $-4,006 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,786 | -3,621 | -2,547 | -1,837 | -3,501 |
| Capital Expenditure | -40 | -97 | -24 | -70 | -164 |
| Free Cash Flow | -3,826 | -3,718 | -2,571 | -1,907 | -3,665 |